Clinical Trials

Uterine Cervical Neoplasms

NCT07493421 2026-03-25

To Evaluate the Feasibility and Safety of Combining Surgery (Pancreatectomy and Cytoreduction) With HIPEC for Treating Pancreatic Cancer With Peritoneal Involvement.

GastrointestinalGynecologic

20 enrolled

Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms, Peritoneal Neoplasms

NCT06476639 2026-03-24

ANVU

Phase 3 Not yet recruiting

640 enrolled

Lymphatic Metastasis, Vulvar Neoplasms

NCT07491081 2026-03-24

EARLY Study: Evaluating the Specificity and Feasibility of the EARLY Biomarker Panel for Ovarian Cancer Detection

1,500 enrolled

Ovarian Neoplasms

NCT07472140 2026-03-16

PARP (Poly (ADP-ribose) Polymerase) Inhibitor With or Without Angiogenesis Inhibitor in Homologous Recombination Deficient Primary Ovarian Cancer, Fallopian-Tube Cancer, or Primary Peritoneal Cancer

Phase 2/3 Recruiting

120 enrolled

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT07472153 2026-03-16

PD-1 (Programmed Death-1) Versus PD-L1 (Programmed Death-ligand 1) Immune Check Point Inhibitors Combined With Chemotherapy, With or Without Bevacizumab, In Patients With Metastatic, Persistent Or Recurrent Cervical Cancer

Phase 2/3 Recruiting

120 enrolled

Uterine Cervical Neoplasms

NCT07431788 2026-03-03

UMAH

60 enrolled

Leiomyoma, Uterine Hemorrhage

NCT07435623 2026-03-02

Late Radiation Toxicities in Cervical and Endometrial Cancer: A Postoperative IMRT/Brachytherapy Study

300 enrolled

Uterine Cervical Neoplasms, Endometrial Neoplasms

NCT06839157 2026-02-25

Artificial Intelligence - Assisted Model for Optimal Timing of Surgery in Advanced Ovarian Cancer

Active not recruiting

1,025 enrolled

Ovarian, Fallopian, and Primary Peritoneal Cancer

NCT03256916 2026-02-24

NELCER

Phase 3 Completed

348 enrolled

Uterine Cervical Neoplasms

NCT03005743 2026-02-23

COMBAT-Cx

Phase NA Completed

1,050 enrolled

Uterine Cervical Neoplasms

NCT05102240 2026-02-20

Development of Clinically High Efficient Platforms for Individualised Treatment of Cervix Cancer

1,800 enrolled

Uterine Cervical Neoplasms

NCT06264167 2026-02-20

NODE

30 enrolled

Lymphatic Metastasis, Vulvar Neoplasms

NCT06644846 2026-02-20

Spatially Fractionated Radiation Treatment for Gynaecological Cancers

20 enrolled

Uterine Cervical Neoplasms, Neoplasms, Recurrence

NCT03997110 2026-02-17

RAPPAL

230 enrolled

Uterine Cervical Neoplasms

NCT07400809 2026-02-17

Retro-COSMOS

350 enrolled

Uterine Cervical Neoplasms, Neoplasm Metastasis, Patient Compliance, Recurrence

NCT05827523 2026-02-13

FOCUS / KOV-04

Phase 3 Recruiting

520 enrolled

Phase 3 Active not recruiting

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT05316181 2026-02-12

KOV-HIPEC-02R

140 enrolled

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT07196033 2026-02-09

AGBR-FERN-Gyn

1,000 enrolled

Stage IIIA Cervical Cancer FIGO 2018

NCT01279135 2026-02-06

PARCER

Phase 3 Completed

300 enrolled

Uterine Cervical Neoplasms

NCT06804135 2026-02-04

STIRR

110 enrolled

Phase 3 Not yet recruiting

Uterine Cervical Neoplasms

NCT07164534 2026-02-04

CHOC-LATE

316 enrolled

Uterine Cervical Neoplasms

NCT07290972 2026-02-04

NCG-Compliance

618 enrolled

Uterine Cervical Neoplasms, Neoplasms, Patient Compliance, Recurrence

NCT07354087 2026-02-04

IMPACTEndoAsia

Active not recruiting

300 enrolled

Endometrial Neoplasms

NCT04073706 2026-01-30

ENDO-3

Phase 3 Recruiting

760 enrolled

Phase NA Not yet recruiting

Uterine Neoplasms, Endometrial Neoplasms

NCT07362147 2026-01-23

Exploring the Effects of Hand and Foot Exercise Intervention in Older Adults With Gynecological Cancer Receiving Chemotherapy Improvement of Peripheral Neuropathy and Quality of Life

74 enrolled